Inactive Instrument

EnteroMedics Inc Stock price Nasdaq

Equities

US29365M2089

Advanced Medical Equipment & Technology

Sales 2023 * 8.9M Sales 2024 * 9.99M Capitalization 3.84M
Net income 2023 * -12M Net income 2024 * -6M EV / Sales 2023 * 0.43 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 0.38 x
P/E ratio 2023 *
-0.04 x
P/E ratio 2024 *
-0.36 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 55.29%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 59 20-01-31
Director of Finance/CFO 63 21-06-14
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 66 15-12-31
Chairman 70 15-10-31
Director/Board Member 70 21-06-14
More insiders
ReShape Lifesciences Inc. is a weight-loss solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease throughout the care continuum. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. Its ReShapeCare virtual health coaching program is a weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShapeMarketplace online store provides top-of-the-line products with bariatric patients in mind. Its ReShapeOptimize supplement options, purchased through the ReShape Marketplace, include multivitamins, probiotics, calcium, vitamin D, protein, and other therapeutic offerings to optimize health.
More about the company
  1. Stock
  2. Equities
  3. Stock ReShape Lifesciences Inc.
  4. Stock EnteroMedics Inc - Nasdaq